New drug candidate SCB0020160 enters first human safety tests
NCT ID NCT07682337
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This phase 1 trial tests a new investigational drug, SCB0020160, for the first time in humans. Healthy adult men aged 18 to 65 receive either the drug or a placebo to evaluate safety, tolerability, and how the drug moves through the body. The study also looks at whether food affects drug absorption. There is no direct health benefit for participants, but results will help determine safe doses for future research in conditions like solid tumors, obesity, and idiopathic pulmonary fibrosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SCB0020160
- What this could lead to
- If safe and well-tolerated, this could pave the way for future studies of SCB0020160 in conditions like solid tumors, obesity, or idiopathic pulmonary fibrosis.
- What could go wrong
- This is an early, first-in-human trial with only 74 healthy men. It is designed to check safety, not to treat disease. Many early-stage drugs fail to show benefit or have unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CMAX Clinical Research Pty Ltd Ground Floor, 21-24 North Terrace
Adelaide, South Australia, 5000, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may spare cancer patients unneeded iron infusions
- Peppermint and lemon scents put to the test against chemo nausea
- Can a new injection help shed excess weight?
- Will a syringe and a vial deliver the same obesity drug dose?
- Can a weekly shot ease sleep apnea without a CPAP machine?
- Fat cell 'Messages' may harm blood vessels — can exercise or surgery stop them?